Ubs Group Ag Neuro Pace Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

A detailed history of Ubs Group Ag transactions in Neuro Pace Inc stock. As of the latest transaction made, Ubs Group Ag holds 4,085 shares of NPCE stock, worth $37,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,085
Previous 4,104 0.46%
Holding current value
$37,745
Previous $31,000 9.68%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.65 - $8.46 $126 - $160
-19 Reduced 0.46%
4,085 $28,000
Q2 2024

Aug 13, 2024
BUY
$6.38 - $15.33 $15,337 - $36,853
2,404 Added 141.41%
4,104 $31,000
Q1 2024

May 13, 2024
BUY
$9.78 - $17.5 $16,626 - $29,750
1,700 New
1,700 $22,000
Q3 2023

Nov 09, 2023
BUY
$4.0 - $9.73 $220 - $535
55 New
55 $0
Q1 2023

May 12, 2023
BUY
$1.44 - $5.34 $1,542 - $5,719
1,071 Added 69.01%
2,623 $12,000
Q4 2022

Feb 08, 2023
SELL
$1.29 - $3.67 $801 - $2,279
-621 Reduced 28.58%
1,552 $2,000
Q3 2022

Nov 10, 2022
BUY
$3.1 - $5.98 $6,736 - $12,994
2,173 New
2,173 $8,000
Q2 2022

Aug 10, 2022
SELL
$4.95 - $8.7 $499 - $878
-101 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$7.06 - $11.57 $25,430 - $41,675
-3,602 Reduced 97.27%
101 $1,000
Q4 2021

Feb 14, 2022
BUY
$8.63 - $17.36 $31,956 - $64,284
3,703 New
3,703 $38,000
Q3 2021

Nov 15, 2021
SELL
$15.85 - $25.07 $40,623 - $64,254
-2,563 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$19.03 - $26.5 $48,773 - $67,919
2,563 New
2,563 $61,000

Others Institutions Holding NPCE

# of Institutions
52
Shares Held
21.3M
Call Options Held
1.3K
Put Options Held
100
View Full List

About NeuroPace Inc

NPCE Quotes by TradingView
  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $230M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email